Irbesartan Tablet
Product Images NDC 33342-049

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 33342-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irbesartan 150mg 30s Mpl

Label for Irbesartan Tablets USP 150 mg, oral tablets manufactured by Macleods Pharmaceuticals Limited and Macleods Pharma USA. The label includes dosage strength, storage instructions (20° to 25°C), quantity of 30 tablets, and barcode information.*

FDA Label Image

Irbesartan 150mg 500s Mpl

Label for Irbesartan Tablets, USP 150 mg oral tablets supplied in a bulk package of 500 tablets. The label shows Macleods Pharma USA as the manufacturer and Macleods Pharmaceuticals Ltd. (India) as the manufacturer of record. Storage instructions and dosing information referral are also included.*

FDA Label Image

Irbesartan 150mg 90s Legacy

Irbesartan Tablets, USP 150 mg oral tablets packaging label from Macleods Pharmaceuticals Limited. The label states each film-coated tablet contains 150 mg of Irbesartan. It includes storage instructions, NDC 33342-048-10, and the package size of 90 tablets. Manufacturer and packager details are also provided.*

FDA Label Image

Irbesartan 150mg Bulk Legacy

Label for bulk shipment of Irbesartan Tablets USP 150 mg by Macleods Pharmaceuticals Limited. The label indicates 6800 tablets, advises handling carefully, and states storage conditions between 20° to 25°C. The label includes an NDC code 33342-048-65 and specifies the tablets are film coated containing 150 mg Irbesartan each.*

FDA Label Image

Irbesartan 300mg 30s Mpl

Irbesartan Tablets, USP 300 mg oral tablets packaging label from Macleods Pharmaceuticals Limited. The label shows quantity of 30 tablets, includes storage instructions, and lists Macleods Pharma USA, Inc. as the manufacturer for the U.S. market with manufacturing in Daman, India. The package is marked Rx Only and displays the NDC 33342-049-07.*

FDA Label Image

Irbesartan 300mg 500s Mpl

Label for Irbesartan Tablets USP 300 mg oral tablets by Macleods Pharmaceuticals Limited. The label indicates each film-coated tablet contains 300 mg of Irbesartan. It includes storage instructions and notes that the bulk package contains 500 tablets and is not for retail dispensing. Manufactured for Macleods Pharma USA, Inc.*

FDA Label Image

Irbesartan 300mg 90s Legacy

Label for Irbesartan Tablets USP, 300 mg oral tablets. The label indicates the product is manufactured by Macleods Pharmaceuticals Ltd and packaged by Legacy Pharmaceutical Packaging LLC. It contains 90 tablets and includes storage instructions and a barcode.*

FDA Label Image

Irbesartan 300mg 90s Mpl

Label for Irbesartan Tablets, USP 300 mg manufactured by Macleods Pharmaceuticals Ltd, distributed by Macleods Pharma USA. The label indicates a 90-tablet oral dosage form, with storage instructions and barcode visible. It specifies that each film-coated tablet contains Irbesartan 300 mg.*

FDA Label Image

Irbesartan 300mg Bulk Legacy

Label for Irbesartan Tablets USP 300 mg, batch packaging of 3400 tablets by Macleods Pharmaceuticals Limited. The label includes storage instructions, a barcode, and a note indicating the product is for repackaging only within six months of manufacture.*

FDA Label Image

Irbesartan 75mg 30s Mpl

Packaging label for Irbesartan Tablets USP, 75 mg, by Macleods Pharmaceuticals Limited. The label states the product is oral tablets, prescription only, with a package count of 30 tablets. Storage instructions indicate 20° to 25°C with permitted excursions. The label includes manufacturer details for Macleods Pharma USA, Inc.*

FDA Label Image

Irbesartan 75mg 500s Mpl

Label for Irbesartan Tablets USP 75 mg, oral film-coated tablets in a bulk package containing 500 tablets. Manufactured by Macleods Pharmaceuticals Limited and Macleods Pharma USA, Inc. Storage instructions include keeping the product at 20° to 25°C with permitted excursions of 15° to 30°C. The label includes usage directions referencing prescribing information.*

FDA Label Image

Irbesartan 75mg 90s Mpl

Label for Irbesartan Tablets USP 75 mg oral tablets by Macleods Pharmaceuticals Limited. The label shows 90 tablets per package, manufacturer information for Macleods Pharma USA, Inc., and recommended storage conditions between 20° to 25°C with permissible excursions. It includes dosage and administration referring to prescribing information and displays barcodes on the sides.*

FDA Label Image

Irbesartan 75mg Bulk Legacy

Irbesartan Tablets USP 75 mg bulk shipment label from Macleods Pharmaceuticals Limited. The label states the product is a film-coated oral tablet containing 75 mg Irbesartan. It includes storage instructions at 20° to 25°C with allowable excursions to 15° to 30°C, and notes it is for repackaging within 6 months of manufacture. The package contains 13,600 tablets.*

FDA Label Image

Irbesartan 75mg100tabcarton

Packaging label for Irbesartan Tablets USP 75 mg in oral tablet form. The label states it contains 100 tablets in 10x10 unit-dose blisters, manufactured by Macleods Pharmaceuticals Limited. The label notes that the pack is not child resistant and includes storage instructions and a barcode.*

FDA Label Image

Irbesartan Figure 1 2

Two dose-response graphs showing the placebo-subtracted reduction in trough systolic and diastolic blood pressure with increasing daily doses of Irbesartan in mg/day. The left graph depicts the reduction in systolic blood pressure (SeSBP), and the right graph shows the reduction in diastolic blood pressure (SeDBP) as dose increases up to 900 mg/day.*

FDA Label Image

Irbesartan Figure 3

A Kaplan-Meier plot displaying cumulative event rates over months of follow-up, comparing the primary endpoint (doubling of serum creatinine, end-stage renal disease, or all-cause mortality) among Irbesartan, Amlodipine, and placebo groups. The chart shows event curves with corresponding risk and p-values for Irbesartan versus placebo and Amlodipine.*

FDA Label Image

Irbesartan (Irbesartan)

Chemical structure of Irbesartan, illustrating its molecular arrangement including a biphenyl group linked to a tetrazole ring and other characteristic chemical moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.